Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|November 7, 2006
[The development of mucosal vaccines]Hilde Bakke, Bjørn Haneberg
Clinical and Vaccine Immunology : CVI|June 17, 2011
Immunization of teenagers with a fifth dose of reduced DTaP-IPV induces high levels of pertussis antibodies with a significant increase in opsonophagocytic activityAudun Aase, Tove Karin Herstad, Samuel Merino, et al.
Infection and Immunity|September 14, 2002
Influence of intravenous anesthesia on mucosal and systemic antibody responses to nasal vaccinesLibuse Janakova, Hilde Bakke, Inger Lise Haugen, et al.
Vaccine|May 6, 2008
Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in NorwayDidrik F Vestrheim, Oistein Løvoll, Ingeborg S Aaberge, et al.
Vaccine|May 20, 2004
Immunisation schedules for non-replicating nasal vaccines can be made simple by allowing time for development of immunological memoryHilde Bakke, Torhild N Setek, Phuong N Huynh, et al.
Vaccine|November 8, 2003
Bordetella pertussis can act as adjuvant as well as inhibitor of immune responses to non-replicating nasal vaccinesAnita Haugan, Phuong Xuan Thi Dao, Nina Glende, et al.
Human Vaccines|October 14, 2006
A non-living nasal influenza vaccine can induce major humoral and cellular immune responses in humans without the need for adjuvantsHelvi Holm Samdal, Hilde Bakke, Fredrik Oftung, et al.
Pageof 1